[go: up one dir, main page]

RU2005107329A - Метод анализа способности соединений или средств снижать активность микросомальной простагландин-e-синтазы или гематопоэтической простагландин-d-синтазы - Google Patents

Метод анализа способности соединений или средств снижать активность микросомальной простагландин-e-синтазы или гематопоэтической простагландин-d-синтазы Download PDF

Info

Publication number
RU2005107329A
RU2005107329A RU2005107329/13A RU2005107329A RU2005107329A RU 2005107329 A RU2005107329 A RU 2005107329A RU 2005107329/13 A RU2005107329/13 A RU 2005107329/13A RU 2005107329 A RU2005107329 A RU 2005107329A RU 2005107329 A RU2005107329 A RU 2005107329A
Authority
RU
Russia
Prior art keywords
prostaglandin
synthase
stage
mixture obtained
final
Prior art date
Application number
RU2005107329/13A
Other languages
English (en)
Russian (ru)
Inventor
Генри МАУ (US)
Генри МАУ
Чжуинь ЛИ (US)
Чжуинь ЛИ
Цзюньцзе СЮН (US)
Цзюньцзе СЮН
Джеффри С СЕЙБОЛ (US)
Джеффри С СЕЙБОЛ
Original Assignee
Авентис Фармасьютикалз Инк. (Us)
Авентис Фармасьютикалз Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0229244.9A external-priority patent/GB0229244D0/en
Application filed by Авентис Фармасьютикалз Инк. (Us), Авентис Фармасьютикалз Инк. filed Critical Авентис Фармасьютикалз Инк. (Us)
Publication of RU2005107329A publication Critical patent/RU2005107329A/ru

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/533Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving isomerase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/99Enzyme inactivation by chemical treatment
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00Screening for compounds of potential therapeutic value
    • G01N2500/04Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Plant Pathology (AREA)
  • Cell Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
RU2005107329/13A 2002-08-16 2003-08-15 Метод анализа способности соединений или средств снижать активность микросомальной простагландин-e-синтазы или гематопоэтической простагландин-d-синтазы RU2005107329A (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US40400802P 2002-08-16 2002-08-16
US60/404,008 2002-08-16
GBGB0229244.9A GB0229244D0 (en) 2002-08-16 2002-12-16 Method for assaying compounds for inhibition of the activity of prostaglandin synthase
GB0229244.9 2002-12-16

Publications (1)

Publication Number Publication Date
RU2005107329A true RU2005107329A (ru) 2005-08-27

Family

ID=31889687

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2005107329/13A RU2005107329A (ru) 2002-08-16 2003-08-15 Метод анализа способности соединений или средств снижать активность микросомальной простагландин-e-синтазы или гематопоэтической простагландин-d-синтазы

Country Status (9)

Country Link
EP (1) EP1543327A2 (fr)
JP (1) JP2006511789A (fr)
KR (1) KR20050035885A (fr)
CN (1) CN1675543A (fr)
AU (1) AU2003258278A1 (fr)
CA (1) CA2495391A1 (fr)
IL (1) IL166782A0 (fr)
RU (1) RU2005107329A (fr)
WO (1) WO2004016223A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005267227B2 (en) * 2004-06-30 2010-04-22 Aventis Pharmaceuticals Inc. Methods involving micromosal prostaglandin E2 synthase
JP5164567B2 (ja) * 2005-05-17 2013-03-21 大鵬薬品工業株式会社 慢性副鼻腔炎の重症度および再発性の検査方法
MY154895A (en) 2007-03-30 2015-08-14 Sanofi Aventis Pyrimidine hydrazide compounds as pgds inhibitors
KR100913148B1 (ko) * 2007-04-10 2009-08-19 이금필 자성입자를 포함하는 자기력 기반 바이오 센서
AU2009246446B2 (en) * 2008-05-13 2014-06-26 Cayman Chemical Company, Incorporated Methods for assaying compounds or agents for ability to displace potent ligands of hematopoietic prostaglandin D synthase
CN106943407A (zh) 2010-07-26 2017-07-14 赛诺菲 苯基噁二唑衍生物在制备治疗变应性或炎性疾病的药物中的用途
CN105254655B (zh) * 2015-11-20 2017-03-22 江汉大学 一种基于bodipy的荧光氨基酸及其合成方法与应用
CN109781990A (zh) * 2018-12-25 2019-05-21 无锡市人民医院 一种β-痕迹蛋白检测试剂盒及制备方法
CN113174424B (zh) * 2021-03-15 2023-05-26 合肥康诺生物制药股份有限公司 一种需氧型酶促反应中酶活性的检测方法、判断重组大肠杆菌发酵终点的方法

Also Published As

Publication number Publication date
WO2004016223A3 (fr) 2004-10-21
EP1543327A2 (fr) 2005-06-22
IL166782A0 (en) 2006-01-15
CN1675543A (zh) 2005-09-28
AU2003258278A1 (en) 2004-03-03
KR20050035885A (ko) 2005-04-19
JP2006511789A (ja) 2006-04-06
WO2004016223A2 (fr) 2004-02-26
CA2495391A1 (fr) 2004-02-26

Similar Documents

Publication Publication Date Title
CN102435598B (zh) 一种稳定的hrp酶促化学发光底物液
JPH0354304B2 (fr)
RU2005107329A (ru) Метод анализа способности соединений или средств снижать активность микросомальной простагландин-e-синтазы или гематопоэтической простагландин-d-синтазы
US20200232993A1 (en) Methods and compositions for fluorescent and colorimetric protein quantitation
CN102311730A (zh) 化学发光液,增强化学发光的试剂和方法
Beeler et al. 4‐Aminobutyrate aminotransferase fluorescence studies
EP1038939A1 (fr) Reactifs chimioluminescents et procedes d'analyse par chimioluminescence dans lesquels on utilise lesdits reactifs
JP2006511789A5 (fr)
JPH01305069A (ja) ベンゾトリアゾール誘導体およびそれを含有する発螢光試薬
US20060211122A1 (en) Reagents for the measurement of peroxynitrites
Kulla et al. Reactions of orthophthalaldehyde with ammonia and 2-aminoethanol
JPS61187657A (ja) 新規試薬による螢光検出方法
ES2205001T3 (es) Procedimiento analitico quimioluminiscente.
Kim et al. De novo generation of a bright blue fluorophore from 2-oxoglutarate in biological samples
JP3792898B2 (ja) ペルオキシダーゼ活性の測定方法
JP3792908B2 (ja) ペルオキシダーゼ活性の測定方法
JP5048889B2 (ja) ペルオキシダーゼ活性の測定方法
US20050181364A1 (en) Assay
JP4177498B2 (ja) 酵素免疫測定法
JP3792959B2 (ja) ペルオキシダーゼ活性の測定方法
JP4028648B2 (ja) ペルオキシダーゼ活性の測定方法
JP3839133B2 (ja) 安定化された化学発光試薬
JP3792885B2 (ja) ペルオキシダーゼ活性の測定方法
JP3792897B2 (ja) 新規化学発光試薬及びその製造方法
JP4028647B2 (ja) 新規化学発光試薬及びその製造方法

Legal Events

Date Code Title Description
FA93 Acknowledgement of application withdrawn (no request for examination)

Effective date: 20090302

FA93 Acknowledgement of application withdrawn (no request for examination)

Effective date: 20090302